PHYSIO-CONTROL RESUMES UNRESTRICTED GLOBAL SHIPMENTS OF ITS LIFEPAK DEFIBRILLATORS

REDMOND, WASH. – Feb. 19, 2010 – Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for...


Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.